Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 21 - 40 out of 500 displayed.
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Evolus Expands Leadership Team with Appointments of Key Executives

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  EVOLUS, INC.

Aclaris Announces Closing of Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Aclaris Therapeutics, Inc.

Akcea Therapeutics to Hold Third Quarter 2018 Financial Results Webcast

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Akcea Therapeutics, Inc.

Harvard Bioscience Names Kam Unninayar as Chief Financial Officer

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Harvard Bioscience, Inc.

CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Clearside Biomedical, Inc.

Osmotica Pharmaceuticals plc Announces Closing of Initial Public Offering

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

Chembio Reports Preliminary Third Quarter 2018 Revenue

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Chembio Diagnostics, Inc.

NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

MacroGenics Announces Participation in Three Investor Conferences

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  MacroGenics, Inc

ContraFect to Participate in World Antimicrobial Resistance Congress 2018

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Contrafect Corporation

National Research Corporation to Broadcast its 2018 Third Quarter Conference Call Live on the Internet

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018

INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  INSYS Therapeutics, Inc.

Chembio Announces Proposed Public Offering of Common Stock

Read more ››
By: Nasdaq / GlobenewsWire - 22 Oct 2018
Related companies:  Chembio Diagnostics, Inc.

PinneyAssociates Welcomes Dr. Judy Ashworth, Analgesic Drug Development Expert, and Bernie Simone, Rx-to-OTC Switch and Consumer Product Marketing Executive

BETHESDA, Md., Oct. 22, 2018 /PRNewswire/ -- PinneyAssociates is pleased to welcome Judy Ashworth, M.D., as Chief Medical Officer and... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018

Varian Ranked First in Probability of Repurchase and Overall Manufacturer, System, and Service Performance in 2018 Survey of Radiation Oncology Professionals

PALO ALTO, Calif., Oct. 22, 2018 /PRNewswire/ -- Varian (NYSE: VAR) today announced it has been ranked first in seven categories, including probability of repurchase, overall manufacturer performance, overall system performance and overall service performance in the ServiceTrak Imaging 2018 report... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Varian Medical Systems, Inc.

ACR 2018: Lilly Announces Positive Results for Two Phase 3 Studies of Taltz® (ixekizumab) in Ankylosing Spondylitis (Radiographic Axial Spondyloarthritis)

INDIANAPOLIS, Oct. 22, 2018 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the company will present positive findings from two Phase 3 studies, COAST-V and COAST-W, in adults with ankylosing spondylitis (AS), also referred to as radiographic axial spondyloarthritis (axSpA),... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Eli Lilly and Company

Chardan Serves as Lead Manager for LogicBio Therapeutics

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced today that the firm acted as lead manager in the initial public offering of LogicBio Therapeutics, Inc. (NASDAQ: LOGC), raising aggregate gross proceeds of approximately $70.0 million. LogicBio began trading... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  LOGICBIO THERAPEUTICS, INC. | Chardan Capital Markets, LLC

Chardan Serves as Lead Manager for Krystal Biotech

NEW YORK, Oct. 22, 2018 /PRNewswire/ -- Chardan, a global investment bank, announced that the firm is acting as lead manager in the follow-on offering for Krystal Biotech, Inc. (NASDAQ: KRYS), a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  Krystal Biotech, Inc.

IDx and Topcon sign exclusive AI platform agreement for the U.S. market

CORALVILLE, Iowa and OAKLAND, N.J., Oct. 22, 2018 /PRNewswire/ -- IDx, a leading AI diagnostics company, and Topcon, one of the world's leading ophthalmic device manufacturers, have signed an exclusivity agreement that will allow the companies... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
Related companies:  IDx Technologies, Inc.

Medline Awarded Lab Distribution Agreement with Premier

NORTHFIELD, Ill., Oct. 22, 2018 /PRNewswire/ -- Medline has been... Read more ››

By: PR Newswire Association LLC. - 22 Oct 2018
«  1 2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑